These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21330379)

  • 21. Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia.
    Blalock WL; Navolanic PM; Steelman LS; Shelton JG; Moye PW; Lee JT; Franklin RA; Mirza A; McMahon M; White MK; McCubrey JA
    Leukemia; 2003 Jun; 17(6):1058-67. PubMed ID: 12764369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purpurogallin is a novel mitogen-activated protein kinase kinase 1/2 inhibitor that suppresses esophageal squamous cell carcinoma growth in vitro and in vivo.
    Xie X; Zu X; Liu F; Wang T; Wang X; Chen H; Liu K; Wang P; Liu F; Zheng Y; Bode AM; Dong Z; Kim DJ
    Mol Carcinog; 2019 Jul; 58(7):1248-1259. PubMed ID: 31100197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of Bifunctional Oncogenic Target Inhibitors against Allosteric Mitogen-Activated Protein Kinase (MEK1) and Phosphatidylinositol 3-Kinase (PI3K).
    Van Dort ME; Hong H; Wang H; Nino CA; Lombardi RL; Blanks AE; Galbán S; Ross BD
    J Med Chem; 2016 Mar; 59(6):2512-22. PubMed ID: 26943489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epimagnolin targeting on an active pocket of mammalian target of rapamycin suppressed cell transformation and colony growth of lung cancer cells.
    Yoo SM; Lee CJ; Kang HC; Lee HS; Lee JY; Kim KD; Kim DJ; An HJ; Cho YY
    Mol Carcinog; 2019 Jul; 58(7):1221-1233. PubMed ID: 30887599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyanidin suppresses ultraviolet B-induced COX-2 expression in epidermal cells by targeting MKK4, MEK1, and Raf-1.
    Kim JE; Kwon JY; Seo SK; Son JE; Jung SK; Min SY; Hwang MK; Heo YS; Lee KW; Lee HJ
    Biochem Pharmacol; 2010 May; 79(10):1473-82. PubMed ID: 20096264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TGF-alpha increases human mesenchymal stem cell-secreted VEGF by MEK- and PI3-K- but not JNK- or ERK-dependent mechanisms.
    Wang Y; Crisostomo PR; Wang M; Markel TA; Novotny NM; Meldrum DR
    Am J Physiol Regul Integr Comp Physiol; 2008 Oct; 295(4):R1115-23. PubMed ID: 18685072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic inhibition of ovarian cancer cell growth by combining selective PI3K/mTOR and RAS/ERK pathway inhibitors.
    Sheppard KE; Cullinane C; Hannan KM; Wall M; Chan J; Barber F; Foo J; Cameron D; Neilsen A; Ng P; Ellul J; Kleinschmidt M; Kinross KM; Bowtell DD; Christensen JG; Hicks RJ; Johnstone RW; McArthur GA; Hannan RD; Phillips WA; Pearson RB
    Eur J Cancer; 2013 Dec; 49(18):3936-44. PubMed ID: 24011934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct targeting of MEK1/2 and RSK2 by silybin induces cell-cycle arrest and inhibits melanoma cell growth.
    Lee MH; Huang Z; Kim DJ; Kim SH; Kim MO; Lee SY; Xie H; Park SJ; Kim JY; Kundu JK; Bode AM; Surh YJ; Dong Z
    Cancer Prev Res (Phila); 2013 May; 6(5):455-65. PubMed ID: 23447564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cocoa procyanidins suppress transformation by inhibiting mitogen-activated protein kinase kinase.
    Kang NJ; Lee KW; Lee DE; Rogozin EA; Bode AM; Lee HJ; Dong Z
    J Biol Chem; 2008 Jul; 283(30):20664-73. PubMed ID: 18519570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ADA-07 Suppresses Solar Ultraviolet-Induced Skin Carcinogenesis by Directly Inhibiting TOPK.
    Gao G; Zhang T; Wang Q; Reddy K; Chen H; Yao K; Wang K; Roh E; Zykova T; Ma W; Ryu J; Curiel-Lewandrowski C; Alberts D; Dickinson SE; Bode AM; Xing Y; Dong Z
    Mol Cancer Ther; 2017 Sep; 16(9):1843-1854. PubMed ID: 28655782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual Inhibition of MEK and PI3K/Akt Rescues Cancer Cachexia through both Tumor-Extrinsic and -Intrinsic Activities.
    Talbert EE; Yang J; Mace TA; Farren MR; Farris AB; Young GS; Elnaggar O; Che Z; Timmers CD; Rajasekera P; Maskarinec JM; Bloomston M; Bekaii-Saab T; Guttridge DC; Lesinski GB
    Mol Cancer Ther; 2017 Feb; 16(2):344-356. PubMed ID: 27811010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphoinositol 3-kinase, a novel target molecule for the inhibitory effects of juglone on TPA-induced cell transformation.
    Chae JI; Cho JH; Kim DJ; Lee KA; Cho MK; Nam HS; Woo KM; Lee SH; Shim JH
    Int J Mol Med; 2012 Jul; 30(1):8-14. PubMed ID: 22505246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of glycogen synthase kinase 3beta in the transformation of epidermal cells.
    Ma C; Wang J; Gao Y; Gao TW; Chen G; Bower KA; Odetallah M; Ding M; Ke Z; Luo J
    Cancer Res; 2007 Aug; 67(16):7756-64. PubMed ID: 17699780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cocoa polyphenols suppress TNF-α-induced vascular endothelial growth factor expression by inhibiting phosphoinositide 3-kinase (PI3K) and mitogen-activated protein kinase kinase-1 (MEK1) activities in mouse epidermal cells.
    Kim JE; Son JE; Jung SK; Kang NJ; Lee CY; Lee KW; Lee HJ
    Br J Nutr; 2010 Oct; 104(7):957-64. PubMed ID: 20550744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Luteolin inhibits protein kinase C(epsilon) and c-Src activities and UVB-induced skin cancer.
    Byun S; Lee KW; Jung SK; Lee EJ; Hwang MK; Lim SH; Bode AM; Lee HJ; Dong Z
    Cancer Res; 2010 Mar; 70(6):2415-23. PubMed ID: 20215519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isorhamnetin inhibited the proliferation and metastasis of androgen-independent prostate cancer cells by targeting the mitochondrion-dependent intrinsic apoptotic and PI3K/Akt/mTOR pathway.
    Cai F; Zhang Y; Li J; Huang S; Gao R
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32039440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of the B-Raf/Mek/Erk MAP kinase pathway as a target for all-trans retinoic acid during skin cancer promotion.
    Cheepala SB; Yin W; Syed Z; Gill JN; McMillian A; Kleiner HE; Lynch M; Loganantharaj R; Trutschl M; Cvek U; Clifford JL
    Mol Cancer; 2009 May; 8():27. PubMed ID: 19432991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TGFbeta inhibits GM-CSF-induced phosphorylation of ERK and MEK in human myeloid leukaemia cell lines via inhibition of phosphatidylinositol 3-kinase (PI3-k).
    Montenegro DE; Franklin T; Moscinski LC; Zuckerman KS; Hu XT
    Cell Prolif; 2009 Feb; 42(1):1-9. PubMed ID: 19143758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
    Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
    Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Luteolin, a novel natural inhibitor of tumor progression locus 2 serine/threonine kinase, inhibits tumor necrosis factor-alpha-induced cyclooxygenase-2 expression in JB6 mouse epidermis cells.
    Kim JE; Son JE; Jang YJ; Lee DE; Kang NJ; Jung SK; Heo YS; Lee KW; Lee HJ
    J Pharmacol Exp Ther; 2011 Sep; 338(3):1013-22. PubMed ID: 21705614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.